|
Status |
Public on May 02, 2024 |
Title |
ESR1 fusions invoke breast cancer subtype-dependent enrichment of ligand independent oncogenic signatures and phenotypes |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
39207954 |
NIH grant(s) |
Grant ID |
Grant title |
Affiliation |
Name |
F30 CA250167 |
Functional Characterization and Clinical Prevalence of ESR1 Fusions in Advanced Endocrine Resistant Breast Cancer |
UNIVERSITY OF PITTSBURGH AT PITTSBURGH |
Megan Yates |
|
|
Submission date |
May 01, 2024 |
Last update date |
Oct 08, 2024 |
Contact name |
Megan E. Yates |
Organization name |
University of Pittsburgh
|
Lab |
Lee-Oesterreich Lab
|
Street address |
5051 Centre Ave
|
City |
Pittsburgh |
State/province |
PA |
ZIP/Postal code |
15213 |
Country |
USA |
|
|
Platforms (2) |
GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
GPL30173 |
NextSeq 2000 (Homo sapiens) |
|
Samples (50)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE249723 |
ESR1 fusions invoke breast cancer subtype-dependent enrichment of ligand independent oncogenic signatures and phenotypes [RNA-seq] |
GSE266407 |
ESR1 fusions invoke breast cancer subtype-dependent enrichment of ligand independent oncogenic signatures and phenotypes [ChIP-seq] |
|
Relations |
BioProject |
PRJNA1106988 |